Tango Therapeutics, Inc. (TNGX)
25.31
+1.25
(+5.20%)
USD |
NASDAQ |
Apr 15, 16:00
25.35
+0.04
(+0.16%)
After-Hours: 18:30
Tango Therapeutics Research and Development Expense (Annual) : 129.88M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Revolution Medicines, Inc. | 978.68M |
| Kodiak Sciences, Inc. | 182.37M |
| Hims & Hers Health, Inc. | 149.30M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Terns Pharmaceuticals, Inc. | 77.89M |